Scientific Advisor

Dr. Lamming is an Assistant Professor of medicine in endocrinology, diabetes, and metabolism at the University of Wisconsin-Madison School of Medicine and Public Health, where he also co-directs the Mouse Metabolic Phenotyping Platform.

 

He has a joint appointment as a research health scientist in the VA Non-Clinician Intramural Research Program at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. He is a renown expert in the field of mTOR biology and the 2018 recipient of the prestigious Nathan Shock New Investigator Award awarded by the Gerontological Society of America (GSA). His research focuses on the basic cellular biology of aging, including regulation of lifespan and healthspan by regulatory deacetylase proteins and the mechanistic target of rapamycin (mTOR) signaling pathway.

 

He has published primary research reports in several prestigious journals, including Science and Nature. He is the principal investigator on several current research grants, including multiple projects funded by the National Institute on Aging.

 

Dr. Lamming serves on the Board of Directors for the American Aging Association.